Fluidigm to Announce Q4/Full Year 2013 Financial Results and Host Conference Call for Investors SOUTH SAN FRANCISCO, Calif., Jan. 31, 2014 — Fluidigm Corporation (NASDAQ:FLDM) will report its fourth quarter and 2013 full year financial results on February 6, 2014, after close of market.
Fluidigm Announces Pricing of $175 Million Convertible Senior Notes Offering SOUTH SAN FRANCISCO, CALIFORNIA, – January 30, 2014 – Fluidigm Corporation (NASDAQ: FLDM), a supplier of microfluidic systems for growth markets in the life science and agricultural biotechnology industries, today
Fluidigm Announces Proposed $175 Million Convertible Senior Notes Offering SOUTH SAN FRANCISCO, CALIFORNIA – January 29, 2014 – Fluidigm Corporation (NASDAQ: FLDM), a supplier of microfluidic systems for growth markets in the life science and agricultural biotechnology industries, today
Fluidigm Announces Preliminary Fourth Quarter 2013 Revenue and Issues 2014 Revenue Guidance SOUTH SAN FRANCISCO, Calif. – Jan. 14, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced total revenue for the fourth quarter of 2013 is expected to be approximately $21 million based on
Fluidigm to Present at the 32nd Annual J.P. Morgan Healthcare Conference SOUTH SAN FRANCISCO, Calif. – Jan. 8, 2014 – Fluidigm Corporation (NASDAQ:FLDM) today announced that President and Chief Executive Officer Gajus Worthington will present at the 32nd Annual J.P.
Nature Selects "Single-Cell Sequencing" as the 2013 Method of the Year
Fluidigm Technology Accelerates the Adoption and Impact of Single-Cell Sequencing
Fluidigm Launches Single-Cell DNA Sequencing Workflow to Study Somatic Mutations in Heterogenous Samples
Universal Sample Prep Workflow on C1™ Single-Cell Auto Prep System Simplifies Genome-Wide and Targeted Sequencing
